Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 9Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 21Head and Neck Neoplasms 17Prostatic Neoplasms 15Neoplasms 13Lung Neoplasms 12Radiation Injuries 9Esophageal Neoplasms 8Rectal Neoplasms 7Glioma 7Brain Neoplasms 7Glioblastoma 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Carcinoma, Hepatocellular 4Stomach Neoplasms 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Astrocytoma 3Xerostomia 2Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Pelvic Neoplasms 2Osteoradionecrosis 2Lymphedema 2Kidney Neoplasms 2Esthesioneuroblastoma, Olfactory 2

Interventions

lenvatinib 3Surgical Procedures, Operative 3Hepatectomy 3Cholangiopancreatography, Endoscopic Retrograde 3Blood Specimen Collection 3Oxaliplatin 2Liquid Biopsy 2Immunohistochemistry 2Immune Checkpoint Inhibitors 2Drug Therapy 2Base Sequence 2pembrolizumab 1gemcitabine-oxaliplatin regimen 1envafolimab 1Vascular Endothelial Growth Factor A 1Urination 1Tegafur 1Shadowing Technique, Histology 1S 1 (combination) 1Radiotherapy 1Quality of Life 1Polymerase Chain Reaction 1Photochemotherapy 1Patient Reported Outcome Measures 1Pancreaticoduodenectomy 1Palliative Care 1Observation 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Microbiota 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Cholangiocarcinoma × Radiotherapy × Clear all
NCT06369480 2024-04-17

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

Rigshospitalet, Denmark

Unknown
2,000 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡